Rivastigmine is an acetylcholinesterase and butyrylcholinesterase inhibitor used for the treatment of Alzheimer’s disease, leading to a reduction in the cognitive decline associated with cholinergic neuron degeneration. The gene discussed is ACHE; the disease is Alzheimer disease.